Fairvalue-Calculator Fairvalue-Calculator
EN DE

Renhe Pharmacy Co (000650) Fair Value & Analysis

Industrials · CN · Market cap 278B KRW

Price202,000 KRW
Fair Value30,220 KRW
Upside-85.0%
Quality95/100
Evidence: Low Range 22,665 KRW – 37,775 KRW

Analysis

Renhe Pharmacy Co (000650) currently trades at 202,000 KRW, while our model-based Fair Value estimate is 30,220 KRW — implying the stock looks roughly 85.0% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is based in Nanchang, China.

Open the full interactive analysis →

Similar stocks

Union Pacific Corporation (UNP) -44% CSX Corporation (CSX) -72% Canadian Pacific Kansas City Limited (CP) -42% Canadian National Railway Company (CNI) -19% Norfolk Southern Corporation (NSC) -61% Westinghouse Air Brake Technologies Corporation (WAB) -46%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.